PDS Biotechnology Corp 8-K

What Happened
PDS Biotechnology Corporation (PDSB) issued a press release on March 30, 2026 announcing a business update and its financial results for the year ended December 31, 2025. The company furnished the press release as Exhibit 99.1 to a Current Report on Form 8-K under Item 2.02 (Results of Operations and Financial Condition). The filing states the information is "furnished" (not "filed") under General Instruction B.2 of Form 8‑K.

Key Details

• Date filed: March 30, 2026; reporting period: year ended December 31, 2025.
• The press release containing the business update and FY2025 results is attached as Exhibit 99.1 to the 8-K.
• The company designated the material as "furnished" (not subject to Section 18 liability and not automatically incorporated by reference into other filings).

Why It Matters
This filing signals PDSB has released its full-year 2025 operating and financial information—key data (earnings, revenue, cash position, or guidance) that investors use to assess company performance and runway. Because the release was furnished rather than filed, investors should read the press release and any accompanying filings (e.g., Form 10-K or future 8-Ks) for the detailed numbers and formal disclosures before making investment decisions.